CXCR4 and breast cancer: Another interesting and recently proposed biomarker of BM development from BC is leptin; in fact, it is associated with the induction of BC cells metastasis to bone tissue through the activation of the SDF-1/CXCR4 signaling and the induction of the EMT (Duan et al., 2020).